| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Product containing clarithromycin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing dicloxacillin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing mafenide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing nitrofurantoin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing spectinomycin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Medicinal product containing natural penicillin and acting as antibacterial agent (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing sulfaguanidine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Medicinal product containing first generation cephalosporin and acting as antibacterial agent (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| médicament contenant amoxicilline et acide clavulanique |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Tobramycin-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Medicinal product containing beta-lactam and acting as antibacterial agent (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Medicinal product containing aminopenicillin and acting as antibacterial agent (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing nafcillin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing gramicidin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing carbomycin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing teicoplanin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Tiamulin-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Tylosin-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing virginiamycin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing apramycin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing azithromycin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Cefpirome (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing cefpodoxime (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing ceftibuten (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing cefixime (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing cefsulodin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Cefprozil-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Cefodizime-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing meropenem (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Amdinocillin (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing pivmecillinam (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing temocillin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Flucloxacillin-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing pivampicillin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing talampicillin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing lymecycline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing cinoxacin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing enoxacin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ofloxacin-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing levofloxacin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing lomefloxacin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing sparfloxacin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing temafloxacin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing rosoxacin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aztreonam 20mg/mL injection solution 50mL plastic container |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aztreonam 40mg/mL injection solution 50mL plastic container |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Amoxicillin + clavulanate potassium 200mg/28.5mg/5mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Clarithromycin 1000mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing tyrothricin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Prednisolone acetate + sulfacetamide sodium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Rifapentine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Clindamycin hydrochloride 75mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Clindamycin hydrochloride 150mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely gentamicin sulfate 3 milligram/1 milliliter conventional release eye solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing fluorometholone and tobramycin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Tobramycin 0.3%/fluorometholone 0.1% ophthalmic suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ketolide-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing tazobactam (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing phenazopyridine hydrochloride and sulfamethoxazole and trimethoprim |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Phenazopyridine hydrochloride 200 mg and sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ciprofloxacin+hydrocortisone |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Sulfasalazine [gastro-intestinal use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aminoglycosides [respiratory use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Tobramycin [respiratory use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ampicillin+penicillinase-resistant penicillin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Amoxycillin [2] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Amoxycillin [generic additions] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Other penicillins |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Cephalosporins & cephamycins |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Cefsulodin sodium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Moxalactam disodium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Tetracyclines [systemic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Tetracycline [systemic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Chlortetracycline hydrochloride [systemic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Gentamicin [infections] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Framycetin sulfate [systemic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Neomycin sulfate [systemic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Tobramycin [systemic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Erythromycin [2] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Clindamycin and lincomycin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Chloramphenicol [systemic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Polymyxin B sulf [systemic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Sulfonamides and trimethoprim |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Co-trimoxazole [generic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Co-trimoxazole [proprietary] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Urinary antimicrobial drugs |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Fosfomycin trometamol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Vaginal antibacterial preparations |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Mixed antibacterial vaginal preparations |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Lidocaine- and neomycin- and polymyxin B-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing neomycin and polymyxin B and pramocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Sulfacetamide sulfate + sulfur |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing clavulanic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing clavulanate potassium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing gramicidin d |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Lincomycin hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Moxifloxacin hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Bacitracin- and neomycin- and polymyxin B- and pramocaine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing neomycin and polymyxin B (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing nitrofurantoin macrocrystal and nitrofurantoin monohydrate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Sulfasalazine [musculoskeletal use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bactericide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]